Delivery Order SPE2DB25D3404-SPE2DB26FULYB
- Not listed
- The Defense Logistics Agency awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs under a firm fixed price contract. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a non-set-aside competitive award, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 26, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Provocholine inhalation solution in 18 mL packs. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA and is scheduled for completion by August 28, 2025. The product will be delivered to the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,459.23 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of November 4, 2025. This contract was competitively awarded without set-aside designation and utilizes firm fixed price pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML pack quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Provocholine Inhalation Solution in 18ml pack quantities, with a contract ceiling value of $9,767.18. This non-competitive delivery order represents a firm fixed price transaction with a completion date of October 24, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite...
- This delivery order, valued at $2,423.36, awards AmerisourceBergen Drug Corp the supply of Provocholine inhalation solution in 18ML packs. The contract was competitively awarded without a set-aside designation on September 22, 2025, with an ultimate completion date of September 23, 2025. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. The Defense Logistics Agency, which serves as the funding federal agency, utilizes this delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Provocholine Inhalation Solution in 18ML packs, with a ceiling value of $2,601.79. This competitive award, made without a set-aside designation, represents a firm fixed-price delivery order for pharmaceutical products to support federal medical procurement needs. The order is expected to be completed by August 27, 2025, with performance taking place at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $18,702.98 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Provocholine 100 mg vials, with an ultimate completion date of November 7, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Provocholine 100 mg vials, valued at $27,352.78. The award is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. The ultimate completion date is set for September 3, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB26FULYBDelivery Order
The Defense Logistics Agency awarded a $2,039.43 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with performance in Conshohocken, Pennsylvania and completion scheduled for November 5, 2025. This is a firm fixed-price delivery order issued without set-aside designation, reflecting competitive award to the prime contractor based on open competition capabilities. The delivery order represents a child action under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio supplying medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Provocholine delivery represents a single transaction within the company's extensive medical supply chain capabilities, which demonstrate versatility in fulfilling federal procurement requirements ranging from nominal to substantial orders under the DLA's Pharmaceutical Prime Vendor Global Program framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/4/25 |